Apertue Venture Partners

www.aperturevp.com

VCMatch tracks Apertue Venture Partners as an investor focused on Medtech, Pharma, and Digital Health companies. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Not specified

Focus Areas

Medtech, Pharma, Digital Health

Geography

Not specified

Investment Thesis

Aperture positions itself as a sector-focused, operator-backed healthcare investor that partners closely with founders to build companies across medical devices, pharmaceuticals, diagnostics and healthcare IT/services. The firm emphasizes working “with exceptional entrepreneurs” and leverages partners who “have deep industry knowledge and a track record of success” to provide board-level guidance, operational support and capital to scale businesses toward exits and commercialization.

Is Apertue Venture Partners right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Apertue Venture Partners is most relevant for founders raising venture-backed rounds in Medtech, Pharma, Digital Health, and Healthtech.

Focus statement

Aperture is "a healthcare-focused investment firm" that invests in medical device, pharmaceutical, healthcare IT/services and diagnostic sectors, partnering with entrepreneurs to build innovative companies and realize clinical and commercial potential.

Value Add

Sector specialization: explicit focus on medical devices, pharmaceuticals, diagnostics and healthcare IT/services (stated on the site).
Operator and clinician experience on the investment team: partners include physicians and healthcare entrepreneurs (e.g., Tony Natale, M.D.; Thomas P. Cooper, M.D.) who provide clinical, operational and customer introductions.
Proven track record of large outcomes: "Aperture has invested in several companies that have achieved valuations exceeding $1 billion" with named examples (Inspire Medical, Axonics, Biohaven, Tarsus, Mako Surgical, etc.).
Hands-on, governance and operational support: partners describe active engagement in building management teams, corporate governance and bringing "operational discipline to R&D and early commercialization efforts."
Broad functional expertise across the team (M&A, capital raising, strategy, business development) through experienced investment professionals.